DUBLIN--(BUSINESS WIRE)--The "Global Epilepsy Monitoring Devices Market by Product (Conventional & Wearable Devices, Standard EEG, Video EEG, Ambulatory EEG, EMG, MEG, Deep Brain Stimulation Devices) End User (Hospitals, Neurology Centres, ASC, Home Care Settings) - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period.
The growth in this market is driven by the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing demand for continuous monitoring, and the rising awareness of neurodegenerative diseases, including epilepsy. On the other hand, the high cost of complex epilepsy monitoring procedures and devices and the unfavorable reimbursement policies are restraining the growth of this market.
The conventional devices segment accounted for the largest share of the epilepsy monitoring devices market in 2020.
Based on products, the epilepsy monitoring devices market has been segmented into wearable devices and conventional devices. The large share of this segment is attributed to rising awareness of neurodegenerative diseases including epilepsy.
The market in Asia Pacific is projected to witness the highest growth rate during the forecast period (2021-2026).
North America accounted for the largest share of the epilepsy monitoring devices market in 2020. The high incidence of neurological disorders, a growing number of clinical trials for epilepsy monitoring devices, and a large number of end users in the US account for their larger market shares.
- Increasing Incidence and Prevalence of Epilepsy
- Rising Awareness of Neurodegenerative Disorders, Including Epilepsy
- Growing Preference for Ambulatory Healthcare and Increasing Use of Wearables
- Growing Demand for Continuous Monitoring
- High Cost of Complex Epilepsy Monitoring Procedures and Devices
- Unfavorable Reimbursement Policies
- Increasing Demand for Non-Invasive and Minimally Invasive Devices
- Expanding Therapeutic Applications of Epilepsy Monitoring Devices
- High Epilepsy Incidence and Growing Healthcare Markets in Emerging Economies
- Shortage of Trained Professionals
- Issues Related to Product Approval and Commercialization
- Natus Medical, Inc.
- Compumedics Limited
- Nihon Kohden Corporation
- The Magstim Co. Ltd.
- Medtronic plc
- Empatica, Inc.
- Masimo Corporation
- Boston Scientific Corporation
- Abbott Laboratories, Inc.
- Aleva Neurotherapeutics S.A.
- Dragerwerk AG & Co. KGaA
- Medpage Ltd.
- Livassured B.V.
- Mjn Neuroserveis, S.L.
- Advanced Brain Monitoring, Inc.
- Lifelines Neuro Company, LLC
- Mitsar Co., Ltd.
- Cgx (A Cognionics Company)
- Mindray Medical International Limited
- Cadwell Industries, Inc.
- Neurowave Systems, Inc.
- Mc10, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/g13dfg